Renee Deehan-kenney PhD

Renee Deehan-Kenney, Ph.D., is a molecular biologist by training and has spent the last decade guiding drug discovery and biomarker development by designing and building high-resolution molecular models of disease and creating systems that find meaning in large-scale biological data.

Prior to QuartzBio, Dr. Deehan-Kenney was VP, Biology & Bioinformatics at PatientsLikeMe where she scaled the computational biology team from inception to 30 members, focused on the development of an integrated research platform, and the generation and analysis of multi-omic and patient-generated health data. In addition, she implemented machine-learning, statistical and systems biology-based modeling approaches, collaborating globally with teams based in China and Israel. Dr. Deehan-Kenney was also the PI for the DigitalMe Ignite program, a nation-wide registry where blood and survey data was collected for multi-omic measurement and analysis to yield insights about personalized health.

Dr. Deehan-Kenney was previously Senior Vice President of Research and Chief Scientific Officer at Selventa. In that role, she set the scientific direction for the company’s personalized medicine strategy and built a multidisciplinary team of biologists and computational biologists to characterize disease biology and identify target pathways. Dr. Deehan-Kenney holds a doctoral degree in molecular and cell biology from the University of California, Berkeley and a bachelor of science degree in bioengineering with a minor in mathematics from the University of Pennsylvania.